{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:19:50Z","timestamp":1791123590362,"version":"4.1.0"},"reference-count":197,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We review recent advances in the use of corticosteroids (CS) in pediatric lung disease. CS are frequently used, systemically or by inhalation. Their mechanisms of action in pulmonary diseases are ill defined. CS exert direct inhibitory effects on many inflammatory cells through genomic mechanisms. There is a time lag before clinical response, and the washout of effects is also prolonged. Prompt relief in some conditions, such as croup, may be related to airway mucosal vasoconstriction through a nongenomic mechanism. CS have proven beneficial roles in the treatment of asthma, croup, allergic bronchopulmonary aspergillosis, and subglottic hemangioma. In some conditions, such as bronchiolitis, cystic fibrosis, and bronchopulmonary dysplasia, their use is controversial and is not recommended routinely. In other conditions, such as tuberculosis, interstitial lung disease, acute lung aspiration, and acute respiratory distress syndrome, CS are often used empirically despite the lack of clear evidence of their benefit. New drug regimens, including the more flexible use of inhaled corticosteroids and long-acting \u03b2-agonists in asthma, the lack of efficacy of oral corticosteroids in preschool children with acute wheeze, the severe complications of systemic dexamethasone used to prevent bronchopulmonary dysplasia and thus more restricted use, and the beneficial effect of pulse high-dose intravenous methylprednisolone in patients with allergic bronchopulmonary aspergillosis or cystic fibrosis are among the major recent developments. There is concern about adverse effects, especially growth and adrenal suppression, induced by systemic CS in children. These have been reduced, but not eliminated, with the use of the inhaled route. The benefits must be weighed against the potential detrimental effects.<\/jats:p>","DOI":"10.1164\/rccm.201107-1174ci","type":"journal-article","created":{"date-parts":[[2011,9,16]],"date-time":"2011-09-16T04:55:15Z","timestamp":1316148915000},"page":"12-23","source":"Crossref","is-referenced-by-count":94,"title":["Corticosteroids in Respiratory Diseases in Children"],"prefix":"10.1093","volume":"185","author":[{"given":"Fernando M.","family":"de Benedictis","sequence":"first","affiliation":[{"name":"Department of Mother and Child Health, Salesi Children's Hospital, Ancona, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bush","sequence":"additional","affiliation":[{"name":"Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,1,1]]},"reference":[{"key":"2026032101082050900_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1099-0496(199607)22:1<44::AID-PPUL7>3.0.CO;2-K","article-title":"The role of corticosteroids in respiratory diseases of children","volume":"22","author":"de Benedictis","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib2","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids: new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1513\/pats.200402-013MS","article-title":"Nongenomic actions of glucocorticosteroids on the airway vasculature in asthma","volume":"1","author":"Wanner","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"2026032101082050900_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1378\/chest.88.2_Supplement.133S","article-title":"Mechanisms of glucocorticoid action in pulmonary disease","volume":"88","author":"Morris","year":"1985","journal-title":"Chest"},{"key":"2026032101082050900_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0954-6111(93)90022-R","article-title":"The mechanism of action of corticosteroids in asthma","volume":"87","author":"Taylor","year":"1993","journal-title":"Respir Med"},{"key":"2026032101082050900_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1067\/mai.2001.116004","article-title":"Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects","volume":"108","author":"Liu","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.200204-298OC","article-title":"Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease","volume":"167","author":"Culpitt","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib8","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1513\/pats.200402-002MS","article-title":"Regulation of inflammatory cell function by corticosteroids","volume":"1","author":"Belvisi","year":"2004","journal-title":"Proc Am Thorac Soc"},{"key":"2026032101082050900_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1067\/mai.2000.107038","article-title":"Delayed eosinophil apoptosis in asthma","volume":"106","author":"Kankaanranta","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2174\/138945011794751555","article-title":"The molecular mechanisms of glucocorticoids-mediated neutrophil survival","volume":"12","author":"Saffar","year":"2011","journal-title":"Curr Drug Targets"},{"key":"2026032101082050900_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1164\/ajrccm\/140.4.951","article-title":"Dexamethasone does not inhibit the release of mediators from human lung mast cells residing in airway, intestine, or skin","volume":"140","author":"Cohan","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1164\/ajrccm\/145.3.669","article-title":"Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma","volume":"145","author":"Djukanovic","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0091-6749(96)80214-4","article-title":"Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions","volume":"87","author":"Schwiebert","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1164\/ajrccm\/143.3.605","article-title":"Corticosteroid inhibition of airway microvascular leakage","volume":"143","author":"Boschetto","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1165\/rcmb.2006-0404OC","article-title":"Effect of dexamethasone and ACC on bacteria-induced mucin expression in human airway mucosa","volume":"37","author":"Hauber","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032101082050900_bib16","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0091-6749(71)90080-7","article-title":"Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone","volume":"48","author":"Booij-Noord","year":"1971","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/0091-6749(87)90204-1","article-title":"Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses and increased bronchial responsiveness to histamine","volume":"79","author":"Cockcroft","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib18","first-page":"167","article-title":"Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction","volume":"63","author":"Dahl","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"2026032101082050900_bib19","first-page":"163","article-title":"The effects of corticosteroids on the immediate asthmatic reaction","volume":"63","author":"Burge","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"2026032101082050900_bib20","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2165\/00003495-200262120-00003","article-title":"Exercise-induced bronchoconstriction","volume":"62","author":"Gotshall","year":"2002","journal-title":"Drugs"},{"key":"2026032101082050900_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1164\/ajrccm.163.1.9807061","article-title":"Acute anti-inflammatory effects of inhaled budesonide in asthma: a randomized controlled trial","volume":"163","author":"Gibson","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib22","first-page":"S70","article-title":"Effects of corticosteroids on airway hyperresponsiveness","volume":"141","author":"Barnes","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1183\/09031936.93.06050652","article-title":"The effect of an inhaled corticosteroid (budesonide) on exercise-induced asthma in children","volume":"6","author":"Waalkens","year":"1993","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/thx.43.5.378","article-title":"Effect of prednisone and beclomethasone dipropionate on airway responsiveness in asthma: a comparative study","volume":"43","author":"Jenkins","year":"1988","journal-title":"Thorax"},{"key":"2026032101082050900_bib25","first-page":"902","article-title":"Effect of corticosteroids on bronchial responsiveness to methacholine in asthmatic children","volume":"131","author":"Bhagat","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib26","first-page":"56","article-title":"Seasonal increase of carbachol airway responsiveness in patients allergic to grass pollen: reversal by corticosteroids","volume":"130","author":"Sotomayor","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0091-6749(83)90054-4","article-title":"The immediate effects of cortisol on pulmonary function in normals and asthmatics","volume":"72","author":"Ramsdell","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib28","first-page":"118","article-title":"The acute effects of corticosteroids in bronchial asthma","volume":"63","author":"Ellul-Micallef","year":"1982","journal-title":"Eur J Respir Dis"},{"key":"2026032101082050900_bib29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/sj.bjp.0707627","article-title":"A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids","volume":"153","author":"Giembycz","year":"2008","journal-title":"Br J Pharmacol"},{"key":"2026032101082050900_bib30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1124\/mol.107.040121","article-title":"Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells","volume":"73","author":"Kaur","year":"2008","journal-title":"Mol Pharmacol"},{"key":"2026032101082050900_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/ajrcmb.23.1.3985","article-title":"Synergistic inhibition by beta 2-agonist and corticosteroids on TNF alpha-induced IL-8 release from cultured human airway smooth-muscle cells","volume":"23","author":"Pang","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032101082050900_bib32","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jaci.2004.07.052","article-title":"Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma","volume":"114","author":"Pace","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1165\/rcmb.2005-0385OC","article-title":"Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells","volume":"34","author":"Edwards","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026032101082050900_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0091-6749(91)90323-G","article-title":"Glucocorticoid therapy for asthma: clinical pharmacology","volume":"88","author":"Szefler","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib35","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pharmthera.2009.11.003","article-title":"Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases","volume":"125","author":"Newton","year":"2010","journal-title":"Pharmacol Ther"},{"key":"2026032101082050900_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1183\/09031936.03.00072402","article-title":"Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids","volume":"21","author":"Mendes","year":"2003","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199503303321307","article-title":"Inhaled glucocorticoids for asthma","volume":"332","author":"Barnes","year":"1995","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM200010123431501","article-title":"Long-term effects of budesonide or nedocromil in children with asthma","volume":"343","author":"The Childhood Asthma Management Program Research Group","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(03)12891-7","article-title":"Early intervention with budesonide in mild persistent asthma: a randomized double-blind trial","volume":"361","author":"Pauwels","year":"2003","journal-title":"Lancet"},{"key":"2026032101082050900_bib40","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1183\/09031936.02.01582001","article-title":"Changes of exhaled nitric oxide during steroid treatment of childhood asthma","volume":"19","author":"Beck-Ripp","year":"2002","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib41","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0091-6749(87)80163-X","article-title":"Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma","volume":"79","author":"Kerrebijn","year":"1987","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/thx.46.7.499","article-title":"Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow","volume":"46","author":"Waalkens","year":"1991","journal-title":"Thorax"},{"key":"2026032101082050900_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1164\/ajrccm\/146.3.547","article-title":"Effects of 22 months of treatment with inhaled corticosteroids and\/or beta-2 agonists on lung function, airway responsiveness, and symptoms in children with asthma","volume":"146","author":"van Essen-Zandvliet","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib44","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1164\/ajrccm\/148.5.1252","article-title":"Cessation of long-term treatment with inhaled corticosteroids (budesonide) in children with asthma results in deterioration","volume":"148","author":"Waalkens","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib45","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1056\/NEJM199409153311103","article-title":"Effects of reducing or discontinuating inhaled budesonide in patients with mild asthma","volume":"331","author":"Haahtela","year":"1994","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib46","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jpeds.2008.11.036","article-title":"Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents","volume":"154","author":"Strunk","year":"2009","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib47","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/adc.2007.116632","article-title":"Daily versus as-needed inhaled corticosteroid for mild persistent asthma (The Helsinki early intervention childhood asthma study)","volume":"93","author":"Turpeinen","year":"2008","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib48","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(10)62145-9","article-title":"Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Martinez","year":"2011","journal-title":"Lancet"},{"key":"2026032101082050900_bib49","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1378\/chest.130.6.1733","article-title":"Budesonide\/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma","volume":"130","author":"Bisgaard","year":"2006","journal-title":"Chest"},{"key":"2026032101082050900_bib50","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/thx.2009.128504","article-title":"Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal","volume":"65","author":"Chapman","year":"2010","journal-title":"Thorax"},{"key":"2026032101082050900_bib51","article-title":"Changes in primary care prescribing patterns for paediatric asthma: a prescribing database analysis","author":"Elkout","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2006.09.042","article-title":"Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial","volume":"119","author":"Sorkness","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib53","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","article-title":"Leukotriene antagonists as first-line or add-on asthma-controller therapy","volume":"364","author":"Price","year":"2011","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib54","first-page":"S44","article-title":"Pharmacology and pharmacokinetics of topical corticosteroids derivatives used for asthma therapy","volume":"141","author":"Check","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"2026032101082050900_bib55","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1345\/aph.1L546","article-title":"Comparison of inhaled corticosteroids: an update","volume":"43","author":"Kelly","year":"2009","journal-title":"Ann Pharmacother"},{"key":"2026032101082050900_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1542\/peds.2010-1223","article-title":"Dose response of inhaled corticosteroids in children with persistent asthma: A systematic review","volume":"127","author":"Zhang","year":"2011","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib57","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.rmed.2006.11.020","article-title":"Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma","volume":"101","author":"Van Aalderen","year":"2007","journal-title":"Respir Med"},{"key":"2026032101082050900_bib58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-3038.2007.00538.x","article-title":"Comparison of the efficacy and safety of ciclesonide 160 \u03bcg once daily vs budesonide 400 \u03bcg once daily in children with asthma","volume":"18","author":"Von Berg","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"2026032101082050900_bib59","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2009.09.021","article-title":"Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma","volume":"124","author":"Lanier","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib60","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1183\/09031936.00030711","article-title":"Pharmacological treatment of severe, therapy resistant asthma in children: what can we learn from where?","volume":"38","author":"Bush","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib61","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1542\/peds.80.2.225","article-title":"Intravenous methylprednisolone efficacy in status asthmaticus of childhood","volume":"80","author":"Younger","year":"1987","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib62","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0140-6736(87)92857-1","article-title":"Effect of a single oral dose of prednisolone in acute childhood asthma","volume":"I","author":"Storr","year":"1987","journal-title":"Lancet"},{"key":"2026032101082050900_bib63","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1542\/peds.92.4.513","article-title":"Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma","volume":"92","author":"Scarfone","year":"1993","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/adc.70.3.170","article-title":"Prednisolone and salbutamol in the hospital treatment of acute asthma","volume":"70","author":"Connett","year":"1994","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib65","first-page":"CD002178","article-title":"Early emergency department treatment of acute asthma with systemic corticosteroids","volume":"1","author":"Rowe","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib66","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1067\/mpd.2003.25","article-title":"Selecting a systemic corticosteroid for acute asthma in young children","volume":"142","author":"Hendeles","year":"2003","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib67","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/bmj.293.6540.169","article-title":"Short course of steroid in home treatment of children with acute asthma","volume":"293","author":"Desphande","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2026032101082050900_bib68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3476(87)80567-X","article-title":"Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators","volume":"110","author":"Harris","year":"1987","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib69","doi-asserted-by":"crossref","first-page":"c843","DOI":"10.1136\/bmj.c843","article-title":"Parent initiated prednisolone for acute asthma in children of school age: randomised controlled crossover trial","volume":"340","author":"Vuillermin","year":"2010","journal-title":"BMJ"},{"key":"2026032101082050900_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1067\/mpd.2001.115021","article-title":"Comparative efficacy of oral dexamethasone versus oral prednisone in acute pediatric asthma","volume":"139","author":"Qureshi","year":"2001","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib71","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1177\/0009922808316988","article-title":"A comparison of oral dexamethasone with oral prednisone in pediatric asthma exacerbations treated in the emergency department","volume":"47","author":"Greenberg","year":"2008","journal-title":"Clin Pediatr (Phila)"},{"key":"2026032101082050900_bib72","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/BF01957010","article-title":"Acute asthma: single dose oral steroids in paediatric community clinics","volume":"153","author":"Horowitz","year":"1994","journal-title":"Eur J Pediatr"},{"key":"2026032101082050900_bib73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1542\/peds.96.2.224","article-title":"Independent parental administration of prednisone in acute asthma: a double-blind, placebo-controlled, crossover study","volume":"96","author":"Grant","year":"1995","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib74","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/01.pec.0000092585.40174.f6","article-title":"Corticosteroids in acute asthma: past present and future","volume":"19","author":"Scarfone","year":"2003","journal-title":"Pediatr Emerg Care"},{"key":"2026032101082050900_bib75","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0954-6111(98)90305-5","article-title":"Prednisolone in acute childhood asthma: clinical responses to three dosages","volume":"92","author":"Langton Hewer","year":"1998","journal-title":"Respir Med"},{"key":"2026032101082050900_bib76","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1378\/chest.122.2.624","article-title":"Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids","volume":"122","author":"Kayani","year":"2002","journal-title":"Chest"},{"key":"2026032101082050900_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mpd.2001.116160","article-title":"Managing acute pediatric asthma: keeping it short","volume":"139","author":"Jones","year":"2001","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib78","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/0140-6736(93)90134-3","article-title":"Double-blind trial of steroid tapering in acute asthma","volume":"341","author":"O'Driscoll","year":"1993","journal-title":"Lancet"},{"key":"2026032101082050900_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0954-6111(95)90191-4","article-title":"A comparison of \u201cabrupt stopping\u201d with \u201ctailing off\u201d oral corticosteroids in acute asthma","volume":"89","author":"Hatton","year":"1995","journal-title":"Respir Med"},{"key":"2026032101082050900_bib80","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1378\/chest.130.5.1301","article-title":"Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation","volume":"130","author":"Rodrigo","year":"2006","journal-title":"Chest"},{"key":"2026032101082050900_bib81","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/rmed.2000.0952","article-title":"Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma","volume":"94","author":"Manjra","year":"2000","journal-title":"Respir Med"},{"key":"2026032101082050900_bib82","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM200009073431003","article-title":"A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma","volume":"343","author":"Schuh","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib83","first-page":"CD002886","article-title":"Corticosteroids for hospitalised children with acute asthma","volume":"2","author":"Smith","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib84","first-page":"CD000195","article-title":"Corticosteroids for preventing relapse following acute exacerbations of asthma","volume":"1","author":"Rowe","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib85","first-page":"CD002316","article-title":"Inhaled steroids in acute asthma following emergency department discharge","volume":"3","author":"Edmonds","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/adc.2009.171272","article-title":"The use of inhaled corticosteroids in the wheezy &lt;5-year-old child","volume":"96","author":"Davies","year":"2011","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"2026032101082050900_bib87","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00002108","article-title":"Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach","volume":"32","author":"Brand","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib88","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa054692","article-title":"Intermittent inhaled corticosteroids in infants with episodic wheezing","volume":"354","author":"Bisgaard","year":"2006","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib89","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMoa051378","article-title":"Long-term inhaled corticosteroids in preschool children at high risk for asthma","volume":"354","author":"Guilbert","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib90","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(06)69285-4","article-title":"Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study","volume":"368","author":"Murray","year":"2006","journal-title":"Lancet"},{"key":"2026032101082050900_bib91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1542\/peds.86.3.350","article-title":"Methylprednisolone therapy for acute asthma in infants and toddlers: A controlled clinical trial","volume":"86","author":"Tal","year":"1990","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/S0022-3476(03)00498-0","article-title":"Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial","volume":"143","author":"Csonka","year":"2003","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib93","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/01.inf.0000215226.69696.0c","article-title":"Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus","volume":"25","author":"Jartti","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"2026032101082050900_bib94","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(03)14685-5","article-title":"Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1\u20135 years: randomised controlled trial","volume":"362","author":"Oommen","year":"2003","journal-title":"Lancet"},{"key":"2026032101082050900_bib95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa0804897","article-title":"Oral prednisolone for preschool children with acute virus-induced wheezing","volume":"360","author":"Panickar","year":"2009","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1359\/jbmr.2003.18.5.913","article-title":"Children and the risk of fractures caused by oral corticosteroids","volume":"18","author":"van Staa","year":"2003","journal-title":"J Bone Miner Res"},{"key":"2026032101082050900_bib97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.prrv.2006.04.010","article-title":"Controversies in the management of preschool viral wheeze","volume":"7","author":"Panickar","year":"2006","journal-title":"Paediatr Respir Rev"},{"key":"2026032101082050900_bib98","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMoa0808907","article-title":"Preemptive use of high-dose fluticasone for virus-induced wheezing in young children","volume":"360","author":"Ducharme","year":"2009","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib99","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.00166508","article-title":"Medicines used in respiratory diseases only seen in children","volume":"34","author":"Lenney","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/adc.72.4.317","article-title":"Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children","volume":"72","author":"Wilson","year":"1995","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib101","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ppul.20591","article-title":"Antiinflammatory pharmacotherapy for wheezing in preschool children","volume":"42","author":"Kaditis","year":"2007","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib102","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1542\/peds.2008-2867","article-title":"Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta analysis","volume":"123","author":"Castro-Rodriguez","year":"2007","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib103","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaci.2008.12.1120","article-title":"Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma","volume":"123","author":"Bacharier","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib104","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0140-6736(06)69077-6","article-title":"Bronchiolitis","volume":"368","author":"Smyth","year":"2006","journal-title":"Lancet"},{"key":"2026032101082050900_bib105","first-page":"CD004878","article-title":"Glucocorticoids for acute viral bronchiolitis in infants and young children","volume":"10","author":"Fernandes","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thorax.58.5.383","article-title":"Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus","volume":"58","author":"van Woensel","year":"2003","journal-title":"Thorax"},{"key":"2026032101082050900_bib107","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1542\/peds.2006-2223","article-title":"Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis","volume":"118","author":"American Academy of Pediatrics","year":"2006","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib108","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1056\/NEJMoa0900544","article-title":"Epinephrine and dexamethasone in children with bronchiolitis","volume":"360","author":"Plint","year":"2009","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib109","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1542\/peds.2009-3663","article-title":"Cost-effectiveness of epinephrine and dexamethasone in children with bronchiolitis","volume":"126","author":"Sumner","year":"2010","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib110","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1152\/japplphysiol.00486.2004","article-title":"Impact of postnatal glucocorticoids on early lung development","volume":"98","author":"Kovar","year":"2005","journal-title":"J Appl Physiol"},{"key":"2026032101082050900_bib111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/1099-0496(200008)30:2<92::AID-PPUL3>3.0.CO;2-X","article-title":"Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus","volume":"30","author":"van Woensel","year":"2000","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib112","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/(SICI)1099-0496(199809)26:3<162::AID-PPUL2>3.0.CO;2-N","article-title":"Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up","volume":"26","author":"Berger","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib113","first-page":"CD004881","article-title":"Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing","volume":"1","author":"Blom","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib114","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0140-6736(08)60170-1","article-title":"Croup","volume":"371","author":"Bjornson","year":"2008","journal-title":"Lancet"},{"key":"2026032101082050900_bib115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJMcp072022","article-title":"Croup","volume":"358","author":"Cherry","year":"2008","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib116","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1542\/peds.83.5.683","article-title":"Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials","volume":"83","author":"Kairys","year":"1989","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib117","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/bmj.319.7210.595","article-title":"The effectiveness of glucocorticoids in treating croup: meta-analysis","volume":"319","author":"Ausejo","year":"1999","journal-title":"BMJ"},{"key":"2026032101082050900_bib118","first-page":"CD001955","article-title":"Glucocorticoids for croup","volume":"1","author":"Russell","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib119","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0140-6736(92)92293-O","article-title":"Placebo-controlled trial of prednisolone in children intubated for croup","volume":"340","author":"Tibballs","year":"1992","journal-title":"Lancet"},{"key":"2026032101082050900_bib120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ppul.1950200604","article-title":"Oral and inhaled steroids in croup: a randomized, placebo-controlled trial","volume":"20","author":"Geelhoed","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib121","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199808203390802","article-title":"A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup","volume":"339","author":"Johnson","year":"1998","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib122","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/jama.279.20.1629","article-title":"Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial","volume":"279","author":"Klassen","year":"1998","journal-title":"JAMA"},{"key":"2026032101082050900_bib123","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijporl.2003.11.017","article-title":"A comparison of nebulized budesonide, and intramuscular, and oral dexamethasone for treatment of croup","volume":"68","author":"Cetinkaya","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2026032101082050900_bib124","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.pec.0000166724.99555.de","article-title":"Budesonide offers no advantage when added to oral dexamethasone in the treatment of croup","volume":"21","author":"Geelhoed","year":"2005","journal-title":"Pediatr Emerg Care"},{"key":"2026032101082050900_bib125","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1542\/peds.106.6.1344","article-title":"Outpatient treatment of moderate croup with dexamethasone: intramuscular versus oral dosing","volume":"106","author":"Rittichier","year":"2000","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib126","first-page":"16","article-title":"Intramuscular versus oral dexamethasone for the treatment of moderate-to-severe croup: a randomized, double-blind trial","volume":"10","author":"Donaldson","year":"2003","journal-title":"Acad Emerg Med"},{"key":"2026032101082050900_bib127","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.pec.0000230552.63799.32","article-title":"Oral betamethasone versus intramuscular dexamethasone for the treatment of mild to moderate viral croup: a prospective, randomized trial","volume":"22","author":"Amir","year":"2006","journal-title":"Pediatr Emerg Care"},{"key":"2026032101082050900_bib128","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/adc.2005.089516","article-title":"Prednisolone versus dexamethasone in croup: a randomised equivalence trial","volume":"91","author":"Sparrow","year":"2006","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1742-6723.2006.00919.x","article-title":"Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial","volume":"19","author":"Fifoot","year":"2007","journal-title":"Emerg Med Australas"},{"key":"2026032101082050900_bib130","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ppul.1950200605","article-title":"Oral dexamethasone in the treatment of croup: 0.15 mg\/kg versus 0.3 mg\/kg versus 0.6 mg\/kg","volume":"20","author":"Geelhoed","year":"1995","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijporl.2006.11.016","article-title":"A randomized comparison of dexamethasone 0.15 mg\/kg versus 0.6 mg\/kg for the treatment of moderate to severe croup","volume":"71","author":"Chub-Uppakarn","year":"2007","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2026032101082050900_bib132","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/MOP.0b013e3283423e6b","article-title":"The new bronchopulmonary dysplasia","volume":"23","author":"Jobe","year":"2011","journal-title":"Curr Opin Pediatr"},{"key":"2026032101082050900_bib133","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000286210","article-title":"Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"2026032101082050900_bib134","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000279992","article-title":"Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"2026032101082050900_bib135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000286212","article-title":"Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review","volume":"98","author":"Doyle","year":"2010","journal-title":"Neonatology"},{"key":"2026032101082050900_bib136","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1542\/peds.2010-1534","article-title":"Committee on Fetus and Newborn. Policy statement: postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia","volume":"126","author":"Watterberg","year":"2010","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib137","doi-asserted-by":"crossref","first-page":"F190","DOI":"10.1136\/adc.2010.187203","article-title":"Minidex: very low dose dexamethasone (0.05 mg\/kg\/day) in chronic lung disease","volume":"96","author":"Yates","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2026032101082050900_bib138","doi-asserted-by":"crossref","first-page":"F158","DOI":"10.1136\/adc.2010.205427","article-title":"Postnatal steroids: the way forward","volume":"96","author":"Halliday","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2026032101082050900_bib139","first-page":"CD001969","article-title":"Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birthweight preterm infants","volume":"4","author":"Shah","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000227294","article-title":"The Neonatal European Study of Inhaled Steroids (NEUROSIS): An EU-funded international randomised controlled trial in preterm infants","volume":"97","author":"Bassler","year":"2010","journal-title":"Neonatology"},{"key":"2026032101082050900_bib141","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1385\/CRIAI:23:1:005","article-title":"The role of inflammation in the pathophysiology of CF lung disease","volume":"23","author":"Chmiel","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026032101082050900_bib142","first-page":"1075","article-title":"Early pulmonary inflammation in infants with cystic fibrosis","volume":"151","author":"Khan","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib143","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/bmj.310.6994.1571","article-title":"Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis","volume":"310","author":"Armstrong","year":"1995","journal-title":"BMJ"},{"key":"2026032101082050900_bib144","doi-asserted-by":"crossref","first-page":"L997","DOI":"10.1152\/ajplung.00156.2002","article-title":"Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis","volume":"284","author":"Corvol","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026032101082050900_bib145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1465-9921-8-88","article-title":"Glucocorticoid receptor gene polymorphisms associated with progression of lung disease in young patients with cystic fibrosis","volume":"8","author":"Corvol","year":"2007","journal-title":"Respir Res"},{"key":"2026032101082050900_bib146","first-page":"55","article-title":"The glucocorticoid receptor: expression, function, and regulation of glucocorticoid responsiveness","author":"Oakley","year":"2001"},{"key":"2026032101082050900_bib147","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MCP.0b013e3282ef9806","article-title":"Anti-inflammatory approaches to cystic fibrosis airways disease","volume":"13","author":"Balfour-Lynn","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"2026032101082050900_bib148","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00148581-200911020-00002","article-title":"The role of inhaled corticosteroids in the management of cystic fibrosis","volume":"11","author":"Ross","year":"2009","journal-title":"Paediatr Drugs"},{"key":"2026032101082050900_bib149","first-page":"CD000407","article-title":"Oral steroids for cystic fibrosis","volume":"2","author":"Cheng","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib150","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib151","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1378\/chest.07-0843","article-title":"Oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbations: a pilot study","volume":"132","author":"Dovey","year":"2007","journal-title":"Chest"},{"key":"2026032101082050900_bib152","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/(SICI)1099-0496(199707)24:1<48::AID-PPUL8>3.0.CO;2-F","article-title":"Lower respiratory illness in infants and young children with cystic fibrosis: evaluation of treatment with intravenous hydrocortisone","volume":"24","author":"Tepper","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib153","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1542\/peds.2009-2042","article-title":"Bolus methylprednisolone efficacy for uncontrolled exacerbations of cystic fibrosis in children","volume":"125","author":"Ghdifan","year":"2010","journal-title":"Pediatrics"},{"key":"2026032101082050900_bib154","first-page":"CD001915","article-title":"Inhaled corticosteroids for cystic fibrosis","volume":"1","author":"Balfour-Lynn","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib155","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1164\/rccm.200511-1808OC","article-title":"CF WISE (Withdrawal of Inhaled Steroids Evaluation) Investigators. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis","volume":"173","author":"Balfour-Lynn","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib156","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpeds.2008.07.010","article-title":"Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis","volume":"153","author":"Ren","year":"2008","journal-title":"J Pediatr"},{"key":"2026032101082050900_bib157","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1164\/rccm.200705-664OC","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"176","author":"Flume","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib158"},{"key":"2026032101082050900_bib159","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1183\/09031936.00077210","article-title":"on behalf of the members of the Belgian CF Registry. Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis","volume":"37","author":"De Boeck","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib160","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis-state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026032101082050900_bib161","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MCP.0b013e32833e24a6","article-title":"Allergic bronchopulmonary aspergillosis and Aspergillus infection in cystic fibrosis","volume":"16","author":"Moss","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"2026032101082050900_bib162","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1513\/pats.200908-086AL","article-title":"Allergic bronchopulmonary aspergillosis","volume":"7","author":"Patterson","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"2026032101082050900_bib163","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2026032101082050900_bib164","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"2026032101082050900_bib165","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in North India","volume":"130","author":"Agarwal","year":"2006","journal-title":"Chest"},{"key":"2026032101082050900_bib166","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"2026032101082050900_bib167","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0954-6111(95)90198-1","article-title":"Invasive pulmonary aspergillosis complicating allergic bronchopulmonary aspergillosis","volume":"89","author":"Ganassini","year":"1995","journal-title":"Respir Med"},{"key":"2026032101082050900_bib168","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1378\/chest.103.1.299","article-title":"Central nervous system aspergillosis following steroidal therapy for allergic bronchopulmonary aspergillosis","volume":"103","author":"Bodey","year":"1993","journal-title":"Chest"},{"key":"2026032101082050900_bib169","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ppul.20333","article-title":"Pulse intravenous methylprednisolone for resistant allergic bronchopulmonary aspergillosis in cystic fibrosis","volume":"41","author":"Thomson","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"Cohen-Cymberknoh","year":"2009","journal-title":"J Cyst Fibros"},{"key":"2026032101082050900_bib171","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"},{"key":"2026032101082050900_bib172","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2010.153312","article-title":"Effects of omalizumab in Aspergillus-associated airway disease","volume":"66","author":"P\u00e9rez-de-Llano","year":"2011","journal-title":"Thorax"},{"key":"2026032101082050900_bib173","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1569-1993(03)00022-5","article-title":"Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450","volume":"2","author":"De Wachter","year":"2003","journal-title":"J Cyst Fibros"},{"key":"2026032101082050900_bib174","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1345\/aph.1D222","article-title":"Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole","volume":"38","author":"Bolland","year":"2004","journal-title":"Ann Pharmacother"},{"key":"2026032101082050900_bib175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0007-0971(79)90073-1","article-title":"Inhaled beclomethasone dipropionate in allergic bronchopulmonary aspergillosis","volume":"73","author":"Report to the Research Committee of the British Thoracic Association","year":"1979","journal-title":"Br J Dis Chest"},{"key":"2026032101082050900_bib176","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1378\/chest.103.5.1614","article-title":"Usefulness of inhaled high-dose corticosteroids in allergic bronchopulmonary aspergillosis","volume":"103","author":"Imbeault","year":"1993","journal-title":"Chest"},{"key":"2026032101082050900_bib177","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1183\/09031936.00146707","article-title":"Nebulised corticosteroid and amphotericine B: an alternative treatment for ABPA?","volume":"31","author":"Laoudi","year":"2008","journal-title":"Eur Respir J"},{"key":"2026032101082050900_bib178","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1378\/chest.107.6.1486","article-title":"Pulmonary tuberculosis and steroids","volume":"107","author":"Cunha","year":"1995","journal-title":"Chest"},{"key":"2026032101082050900_bib179","first-page":"CD001876","article-title":"Corticosteroids for tuberculous pleurisy","volume":"4","author":"Engel","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib180","first-page":"208","article-title":"A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis","volume":"7","author":"Smego","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026032101082050900_bib181","first-page":"373","article-title":"Tuberculosis","author":"Inselman","year":"1994"},{"key":"2026032101082050900_bib182","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/adc.2006.096958","article-title":"Primary ciliary dyskinesia: current state of the art","volume":"92","author":"Bush","year":"2007","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib183","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/adc.2009.171553","article-title":"Characteristics of disorders associated with genetic mutations of surfactant protein C","volume":"95","author":"Thouvenin","year":"2010","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib184","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/(SICI)1099-0496(199811)26:5<332::AID-PPUL5>3.0.CO;2-Q","article-title":"Chronic interstitial lung disease in children: response to high-dose intravenous methylprednisolone pulses","volume":"26","author":"Desmarquest","year":"1998","journal-title":"Pediatr Pulmonol"},{"key":"2026032101082050900_bib185","first-page":"277","article-title":"Idiopatic pulmonary fibrosis: diagnosis and treatment. ATS\/ERS International Consensus Statement","volume":"165","author":"American Thoracic Society\/European Respiratory Society","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101082050900_bib186","first-page":"319","article-title":"Paediatric interstitial lung disease","volume-title":"Eur Respir Mon","author":"Bush","year":"2008"},{"key":"2026032101082050900_bib187","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/cc5976","article-title":"Corticosteroids to prevent postextubation upper airway obstruction: the evidence mounts","volume":"11","author":"Epstein","year":"2007","journal-title":"Crit Care"},{"key":"2026032101082050900_bib188","first-page":"CD001000","article-title":"Corticosteroids for the prevention and treatment of postextubation stridor in neonates, children and adults","volume":"2","author":"Markovitz","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2026032101082050900_bib189","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.otc.2008.04.009","article-title":"Subglottic hemangioma","volume":"41","author":"O-Lee","year":"2008","journal-title":"Otolaryngol Clin North Am"},{"key":"2026032101082050900_bib190","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/archotol.134.8.848","article-title":"Treatment of congenital subglottic hemangiomas: our experience compared with reports in the literature","volume":"134","author":"Saetti","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2026032101082050900_bib191","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ijporl.2010.06.001","article-title":"Propranolol for the treatment of airway hemangiomas: a case series and treatment algorithm","volume":"74","author":"Truong","year":"2010","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"2026032101082050900_bib192","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/adc.74.1.66","article-title":"Steroids for intubated croup masking airway haemangioma","volume":"74","author":"Kiff","year":"1996","journal-title":"Arch Dis Child"},{"key":"2026032101082050900_bib193","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.prrv.2007.03.001","article-title":"Pediatric acute lung injury","volume":"8","author":"Dahlem","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"2026032101082050900_bib194","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N Engl J Med"},{"key":"2026032101082050900_bib195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1136\/bmj.39537.939039.BE","article-title":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis","volume":"336","author":"Peter","year":"2008","journal-title":"BMJ"},{"key":"2026032101082050900_bib196","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1097\/CCM.0b013e3181aee5dd","article-title":"Management of acute lung injury and acute respiratory distress syndrome in children","volume":"37","author":"Randolph","year":"2009","journal-title":"Crit Care Med"},{"key":"2026032101082050900_bib197","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pcl.2008.10.013","article-title":"Aspiration lung disease","volume":"56","author":"de Benedictis","year":"2009","journal-title":"Pediatr Clin North Am"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/1\/12\/67249556\/ajrccm_185_1_12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/1\/12\/67249556\/ajrccm_185_1_12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:08:48Z","timestamp":1774069728000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/185\/1\/12\/8507578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,1]]},"references-count":197,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201107-1174ci","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,1]]},"published":{"date-parts":[[2012,1,1]]}}}